Comparing pain relief methods during breast surgery
Efficacy of Single Level Versus Bilevel Serratus Anterior Plane Block With Dexmedetomidine During Breast Cancer Surgery
NA · National Cancer Institute, Egypt · NCT05361837
This study is testing different ways to relieve pain during breast surgery for cancer patients to see which method works best.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 172 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | National Cancer Institute, Egypt (other) |
| Locations | 1 site (Cairo) |
| Trial ID | NCT05361837 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of single-level and bilevel serratus anterior plane blocks, both with and without the addition of dexmedetomidine, in providing analgesia for cancer patients undergoing modified radical mastectomy. The aim is to assess pain control and potential side effects associated with these techniques. By evaluating different approaches to regional anesthesia, the study seeks to identify the most effective method for managing postoperative pain in this patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are cancer patients aged 18-65 scheduled for modified radical mastectomy with an ASA classification of I-II.
Not a fit: Patients who may not benefit include those with coagulation defects, abnormal kidney or liver functions, local infections at the injection site, or those who refuse participation.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing breast surgery.
How similar studies have performed: Other studies have shown promising results with serratus anterior plane blocks for pain management, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients scheduled for modified radical mastectomy, * Age 18-65 years, * ASA I-II Exclusion Criteria: * patient refusal, * coagulation defects, * abnormal kidney or liver functions, * local infection at site of injection.
Where this trial is running
Cairo
- Walaa Y Elsabeeny — Cairo, Egypt (RECRUITING)
Study contacts
- Principal investigator: Walaa Y Elsabeeny, MD — Assistant Professor of Anesthesia and Pain management
- Study coordinator: Walaa Y Elsabeeny, MD
- Email: walaa.elsabeeny@nci.cu.edu.eg
- Phone: 201007798466
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Analgesia